Boston Scientific Launches $150 Million China Expansion, Shifting Resources From The West
This article was originally published in PharmAsia News
SHANGHAI - U.S. medical device manufacturer Boston Scientific will invest $150 million over the next five years to expand its commercial presence in China and establish R&D and manufacturing operations as the company undergoes a global restructuring initiative
You may also be interested in...
SHANGHAI - China's capital Beijing and Zhejiang Province recently issued long-awaited guidelines to encourage private investment in medical institutions, which is viewed by analysts as a signal that China will implement the policy nationwide and open the gates for private hospitals
SHANGHAI - Johnson & Johnson and its device company in China Johnson & Johnson Medical (Suzhou) Ltd. will open a new innovation center in Suzhou to develop medical devices and diagnostic products for emerging markets in Asia
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).